Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04892017
Title A Phase 1/2 Study of DCC-3116 as Monotherapy and Combination Therapy in Patients With MAPK Pathway Mutant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Deciphera Pharmaceuticals LLC

pancreatic ductal adenocarcinoma

colorectal cancer

Advanced Solid Tumor


lung non-small cell carcinoma


DCC-3116 + Sotorasib

Binimetinib + DCC-3116


DCC-3116 + Trametinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST